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ABSTRACT The actions of the optical enantiomers of BAY K 8644 and Sandoz 
202 791 were studied on barium inward currents recorded using the whole-ceU 
configuration of the patch clamp technique from enzymatically isolated smooth 
muscle cells from the rabbit ear artery. The enantiomers were applied by bath 
perfusion or rapidly by a concentration jump technique, which enabled the study of 
drug action under equilibrium and nonequilibrium conditions. A larger effect of 
agonists was seen on peak inward current in 110 mMBa when small rather than 
large depolarizations were applied. The midpoint voltage of the steady-state inacti- 
vation curve of Iaa was --12.8 -- 1.9 mV (n = 4) in the absence of drug, -16.4 --- 2.5 
mV (n = 4) in 1 ~M (+)202 791, and -31.4 +_ 0.4 mV (n = 4) in 1 p.M ( - )202 791. 
The rate of onset of action of the agonist and antagonist enantiomers of BAY K 
8644 and Sandoz 202 791 was studied by rapid application during 20-ms depolar- 
izing steps from different holding potentials to +30 mV at 1 or 0.2 Hz. The drugs 
were applied as concentration jumps between two single pulses of a pulse train. The 
rates of onset of drug action on peak I~  during a 1-Hz pulse train were concentra- 
tion dependent over the range of 100 nM-3 v,M for both (+) and (-)202 791. The 
rate of onset of inhibition of peak current by antagonist enantiomers was not 
significantly influenced by the test pulse frequency. At a holding potential of -60  
mV, the onset rate of the increase in peak IB~ on application of 1 I~M of agonist 
enantiomers (+)202 791 or (-)BAY K 8644 during a train of pulses occurred with 
mean time constants of 2.1 - 0.7 s (n = 7) and 2.3 -+ 0.2 s (n = 4), respectively. The 
onset of current increase on application of 1 wM (+)202 791 during a single voltage 
clamp step to 20 mV was faster, with a mean time constant of 380 - 80 ms (n = 3). 
INTRODUCTION 
1,4-Dihydropyridine (DHP) compounds interact in a complex way with calcium 
channels in various tissues (Triggle, Skattebol, Rampe, Joslyn, and Gengo, 1986; 
Bechem, Hebisch, and Schramm, 1988; Glossmann and Striessnig, 1990). The 
opposing actions (agonist or antagonist) of  different stereoisomers of  several DHPs 
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on calcium channels demonstrate a highly specific mechanism of drug action (Hof, 
Ruegg, Hof, and Vogel, 1985), which seems to reflect an interaction with the gating 
of L-type calcium channels (Hess, Lansman, and Tsien, 1984; Kokubun, Prod'horn, 
Becker, Porzig, and Reuter, 1986; Hering, Kleppisch, Timin, and Bodewei, 1989b; 
Lacerda and Brown, 1989; Marks and Jones, 1992). There is general agreement that 
agonist DHP compounds increase, whereas antagonist DHPs decrease the open 
probability of L-type calcium channels in heart (Hess et al., 1984; Ochi, Hino, and 
Niimi, 1984), smooth muscle (Yatani, Seidel, Allen, and Brown, 1987) and neuronal 
calcium channels (Nowycky, Fox, and Tsien, 1985). However, agonist drug effects 
have been reported for several different "calcium antagonists" in studies of single 
calcium channels (Hess et al., 1984) as well as whole-cell calcium channel currents 
(Brown, Kunze, and Yatani, 1986; Hering, Beech, and Bolton, 1987b; Kass, 1987; 
Terada, Nakao, Okabe, Kitamura, and Kuriyama, 1987; Aaronson, Bolton, Lang, and 
MacKenzie, 1988). 
Agonist-DHP-induced gating of calcium channels was recently studied directly by 
means of a concentration jump technique. A rapidly occurring equilibration between 
the applied DHP and the calcium channel receptor in such experiments can be 
observed as a corresponding change in membrane conductance on application of the 
drugs during single voltage clamp steps (Hering, Beech, Bolton, and Lim 1988; 
Hering et al., 1989b; Imaizumi, Muraki, Takeda, and Watanabe, 1989). 
The purpose of this study is to investigate the interaction of DHPs with the calcium 
channels in different states (C, O, and I) in isolated arterial smooth muscle cells. The 
voltage-dependent effects of two pairs of DHP enantiomers with agonist and 
antagonist activity (Sandoz 202 791 and BAY K 8644) were compared under 
equilibrium and nonequilibrium conditions. Taking advantage of the less pro- 
nounced rundown of the calcium channel current in isolated ear artery cells 
compared with other preparations (see Benham, Hess, and Tsien, 1987; Hering, 
Bolton, Beech, and Lim, 1989a) and using the technique of rapid solution exchange 
(Hering et al., 1987a), we were able to study for the first time the rate of action of 
agonist and antagonist DHPs in smooth muscle at different membrane potentials. 
METHODS 
Single smooth muscle cells were freshly dispersed from rabbit ear artery using a modified 
procedure of Benham and Bolton (1986). Short segments (1-2 mm) of artery were incubated 
for 1 h in a modified physiological salt solution containing 10 ~M calcium, 2 mg/ml bovine 
serum albumin, 1 mg/ml collagenase (130 U/mg; Worthington Biochemical Corp., Freehold, 
NJ), 0.5 mg/ml papain (15 U/mg; Sigma Immunochemicals, St. Louis, MO), and 5 mM 
dithiothreitol, respectively. Cells were dispersed by mild agitation in this low-calcium physiolog- 
ical salt solution. After centrifugation the cells were resuspended in normal physiological salt 
solution containing (mM): 130 NaCl, 6 KCI, 1.7 CaCl~, 1.2 MgCl2, 14 glucose, and 10.7 HEPES 
buffered to pH 7.4 with NaOH. The cells were stored on coverslips at 4°C and used within 6-8 
h. The experiments were performed using the whole-cell configuration of the patch clamp 
technique (Hamill, Marty, Neher, Sakmann, and Sigworth, 1981) by means of a patch clamp 
amplifier (EPC-7; List-Electronic, Darmstadt, FRG). Patch pipettes had resistances of3-5 MfL 
The internal (pipette) solution contained (mM): 126 NaCI, 3.2 MgSO4, 1 NaH2PO4, 2 EGTA, 
11.5 glucose, 2 Mg~ ATP, 10 TEA and 5 HEPES buffered to pH 7.2 with NaOH. The 
experiments were carried out in high-barium solution containing (mM): 110 BaCI~ and 10 
HEPES buffered to pH 7.4 with TEA-OH. 
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A BBC microcomputer which communicated with a 1401 CED-programmable interface 
provided the voltage clamp command pulses through a 12-bit digital-to-analogue converter. 
Data were recorded on FM tape and later analyzed off-line after analogue-to-digital conversion. 
The currents were low-pass filtered at 1 KHz with an 8-pole Butterworth filter (Barr and Stroud 
Inc., Glasgow, UK). Leak currents were subtracted either digitally using average values of 
steady leakage currents elicited by a 20-mV hyperpolarizing pulse or electronically b  means of 
an analogue circuit. All recordings were made between 20 and 25°C. The current decay was 
fitted to an exponential function using the algorithm of Marquardt (1963). Curve fitting of 
dose-response data was performed by nonlinear egression using GraphPad Inplot 3.0 
A C 
CONTROL IIJM (+) 202 791 
TP (mV) TP 
-50 ~ -50 
-20 to +20 -20 to +10 
__150 pA 
50 ms 50 ms 
TP (mV) ~ ~ ~ T P  (mV) I 
F[GUI1E 1. Effects of the agonist (+)202 791 on calcium channel currents in an arterial 
smooth muscle cell from the rabbit ear artery. (A and B) Inward currents were recorded in 110 
mM extracellular BaCI~, stepping from a holding potential of -60 mV to the indicated test 
potentials (TP) (10-mV steps). (C and D) Currents of the same cell at the same test potentials in 
the presence of 1 ~M (+)202 791. Note the different current calibration i A and B vs. C and D. 
(GraphPad Software, San Diego, CA). The enantiomeric DHPs (+)-(S) 202 791 and (-)-(R) 
202 791 (is•pr•py•-4-(2•••3-benz•xadiaz••-4-y•)-•'4-dihydr•-2•6-dimethy•-5-nitr•-3•pyridine- 
carboxylate) (gifts from Sandoz AG, Basel, Switzerland) and (+) BAY K 8644 and (- )  BAY K 
8644 (otherwise known as BAY R 4427 and BAY K 5417; gifts from Prof. H. Glossmann, 
Institut f~r Biochemische Pharmakologie, Innsbruck, Austria ) were applied by bath perfusion 
or by a concentration jump technique previously described in detail (Hering et al., 1987a). This 
enabled the application of the drugs within < 10 ms (Hering et al., 1987a, 1989a, b). Stable 
whole-cell recordings were made from single cells in a micro-drop formed within an inner bath 
that was separated from an outer bath by a Sylgard polymer ing. The rapid application of new 
solution to the single cell from which recording was made took palce when solution (from the 
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FIGURE 2. (A) The current-voltage r lationship of peak inward currents in control 110 mM 
BaC12 (O) and after application (F-I) of 1 v,M (+)202 791 (same experiment as Fig. 1). (B) The 
current-voltage r lationship of peak inward currents in control 110 mM BaCI2 (O) and after 
application (n) of I p,M (-)BAY K 8644. Currents were recorded from a holding potential of 
-60  mV. 
outer bath) flooded over the Sylgard ring and mixed with the micro-drop. Data are presented 
as mean values -+ SEM, 
RESULTS 
Action of the Enantiomers of Sandoz 202 791 and BAY K 8644 under Equilibrium 
Conditions 
The effects of  the optical enant iomers of 202 791 and BAY K 8644 on the 
current-vol tage r lat ionship of  the peak bar ium current were compared.  The inward 
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TABLE I 
A Comparison of the Effect of Agonist and Antagonist Drugs on Peak Currents (I~ 
Amplitude) Evoked by 200-ms Pulses to -10  or +40 mV from a HoMing Potential of 
-60 mV and Steady-State Inactivation Parameters (1~ Availability) 
397 
IB= amplitude lBa availability 
A t -10mV At +40mV Vh k I. 
(% control) (mV) (mV) (% peak) 
Control 100 100 -12.8 ± 1.9 8.5 ± 3.4 10.7 ± 0.1 
(+)202 791 433 ± 124 244 ± 19 -16.4 --- 2.5 6.7 --- 0.8 4.0 ± 3.0 
(-)BAY K 8644 472 ± 187 238 ± 31 - -  - -  - -  
(-)202 791 82 ± 6 37 ± 6 -31.4 ± 0.4 5.1 - 0.6 0 
(+)BAY K 8644 99 ± 13 45 ± 5 - -  - -  - -  
The values shown are means ± SEM of three or four cells. I wM of each drug was applied. 
currents were recorded before and after a 4-min equilibrium period with the drugs 
during the application of 200-ms pulses from a holding potential of -60 mV at 0.3 
Hz (Fig. 1). 
Both agonist compounds induced a concentration-dependent shif in the peak of 
the current-voltage r lationship (Fig. 2, A and B). In the presence of 1 ~M (+)202 
791 the peak of the current-voltage r lationship was shifted by 10 +-. 3 mV (n = 5) 
and in the presence of (-)BAY K 8644 by 14 -+ 2 mV (n = 4) in the negative 
direction. The drug-induced increase in peak current amplitude was much larger at 
A C 
CONTROL 
-20 to +20 ~ ' ~  
50 pA ! 
B 50 ms D 
t OolPM(-) 202 791 -==b . . . . . . . . .  ~ _  
__160 pA 
50 ms 
TP (mV) 
430 to +70 
FIGURE 3. Effect of  antagonist  DHP enant iomers on bar ium currents of  rabbit ear artery cells. 
(A and B) Inward currents were recorded in 110 mM extracellular BaCI2 stepping from a 
holding potential  of  -60  mV to the indicated TP (10-mV steps). (C and D) Inward currents of 
the same cell in the presence of  0.1 wM ( - )202  791. 
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smal l  depo lar i za t ions  compared  w i th  the  increase  in cur rent  at  vo l tages  near  the  
reversa l  o f  the  cur rent .  A compar i son  o f  the  inc rease  in peak  cur rent  va lues  at test  
potent ia l s  o f  - 10 and  +40 mV is shown in Tab le  I. 
Agon is t  enant iomers  induced  an  increase  in the  t rans ient  component  o f  the  
cur rent .  On  app l i ca t ion  o f  the  antagon is t  ( - )202  791 (0. I  p,M), a decrease  o f  the  
peak  cur rent  was observed  wh ich  was accompan ied  by an  acce le ra t ion  in the  cur rent  
decay  (Fig. 3). In  the  presence  o f  1 ~M ( - )202  791 the  cur rents  now inact ivated  
a lmost  complete ly  dur ing  a 200-ms depo lar i z ing  pu lse .  The  inh ib i to ry  e f fects  o f  
TABLE l I  
Equilibrium data Data from on/off rates 
HP - logEC~0 ECs0 - lOgKD KD Kof~ K_ t 
mV M nM M nM s - I  s - t  
(+) 202 791 
-40  7.21 -+ 0.33 62 7.07 + 0.11 85 0.078 -+ 0.007 (n = 6) 0.1 
-60  6.89 + 0.10 128 7.13 + 0.19 74 0.076 +- 0.005 (n = 4) - -  
-80  6.95 - 0.42 112 7.06 -4- 0.19 87 0.080 --I-- 0.008 (n = 6) - -  
( - )  202 791 
-40  6.97 - 0.03 110 6.60 ± 0.16 250 0.022 --. 0.005 (n = 3) 0.03 
-60  6.28 - 0.08 524 6.34 ~ 0.05 457 0.016 -+ 0.004 (n = 6) 0.017 
-80  5.62 ± 0.38 2,400 5.87 --- 0.11 1,350 0.024 --. 0.005 (n = 3) 0.017 
Stimulation or inhibition of peak 1Ba by (+) or ( - )  202 791, respectively, were studied during 20-ms test 
pulse trains. The equilibrium data -logECs0 (molar) were obtained from dose-response tudies (pulses 
applied at a frequency 0.3 Hz to minimize interaction with open or inactivated channels). The peak lsa 
inhibition or increase at steady state (i.e., after more than three onset time constants when the degree of 
change in peak I~ appeared to be stable) was fit to a logistic expression: y = a+ (b - a)/(l + (10x/10c), 
where a and b are the minimum and maximum of the curve, respectively (maximum constrained to 1 for no 
inhibition in the absence of drug), c = IogECs0, and x = drug concentration assuming a pseudo Hill slope of 
- 1. The apparent KD values from on and off rates were calcualted from the kinetics of peak current changes 
on application of (+) or (-)202 791 during a t-Hz pulse train according to Kon = (I/'ron - Ko~)/[x] with KD 
= KoedK,~,, .  In the calculation the association rate constant (Ko,), %, was taken to be the mean of "ton 
measured at three concentrations of agonist and antagonist used (see Fig. 8, A and B). It should be noted, 
however, that %, for the agonist (+) 202 791 appeared not to be well described by a model based on a 
simple bimolecular interaction which could introduce some error in our estimation of KD. The off rate of 
drug action (Ko~) was estimated from washout of(+) or ( - )  202 791 during a 20-ms pulse (1 Hz) train to 30 
mV by concentration jump application of control solution between two pulses. Alternatively, the dissociation 
rate constant K-l was estimated from the intercept of the l/'r plot against drug concentration asdescribed in 
Fig. 8. 
antagon is t  enant iomers  were ,  in cont ras t  to the  agon is t  act ion ,  less pronounced 
dur ing  smal l  depo lar i z ing  test  pu lses  (see Tab le  II; cf. F igs.  2, A and  B and  4, A and  
B)  and  no  obv ious  shi f t  in the  peak  o f  the  cur rent -vo l tage  re la t ionsh ip  o r  ac t ivat ion  
curve  was observed .  
Agon is t  and  antagon is t  enant iomers  o f  the  s tud ied  DHPs  a f fec ted  the  s teady-s ta te  
inact ivat ion  o f  the  ca lc ium channe l  to d i f fe rent  extents .  The  ca lc ium channe l  
avai labi l i ty was es t imated  by measur ing  the  peak  IBa dur ing  a test  pu lse  to +20 mV 
af ter  a 6-s  cond i t ion ing  prepu lse  wi th  an  in terva l  o f  3 ms  between cond i t ion ing  and  
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FIGURE 4. (A) The current-voltage r lationships of peak inward currents in control 110 mM 
BaCI2 solution (O) and after application of 1 p~M (+) BAY K 8644 (El) currents were recorded 
from a holding potential of -60  inV. (B) The current-voltage r lationship of peak inward 
currents in control 110 mM BaCI, solution (O) and after cumulative application of 0.1 ~M (A) 
and 1 p~M (-)202 791 (I7) (same experiment as Fig. 3). 
test pulses. The data were fitted to the function: 
I / Ima x -~- (1 -- I ss ) /{ l  "4" EXP[(V- Vh)lk]} + I,s 
where I/Imax is the normalized peak inward current evoked during the test pulse after 
a 6-s conditioning pulse, V is the conditioning potential, Vh is the voltage where 50% 
of the channels are available, k is the slope parameter,  and I ,  is a sustained 
component  of IBa that did not inactivate during the 6-s depolarizing prepulse. 
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As shown in Fig. 5, A and B, the agonist enantiomers of  both drugs induced small 
shifts in the midpoint voltage of the steady-state inactivation curve to more hyperpo- 
larized voltages. In an additional series of  experiments we studied the dose depen- 
dency of  the shift in the midpoint voltage of the availability by agonists and 
antagonists using a pulse protocol with 10-s prepulses. Under these conditions 100 
nM, 300 nM, and 1 ~M of the agonist (+)202 791 induced mean shifts of 1.6, 6.8, 
and 10.5 mV (n = 3), respectively, in the hyperpolarizing direction. The correspond- 
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FIGURE 5. Effect of agonist 
DHP enantiomers on the volt- 
age dependence ofIBa availabil- 
ity. The peak currents during a 
200-ms test pulse to +20 mV 
were plotted versus the voltage 
of a 6-s conditioning prepuise. 
Interpulse interval was 3 ms. 
Solid lines are drawn according 
to the equation I/Im~, = (1 -- 
Iss){1 + exp[(V - Vh)/k]} + lss- 
(A) Effect of (+)202 791 on the 
voltage dependence of Isa avail- 
ability. Under control condi- 
tions (O) l~x = 87 pA, Vh = 
--14.5 mV, k = 11.2 mV, and 
Is, = 5 pA, and after applica- 
tion of 1 o.M (+)202 791 ( . )  
/max = 336 pA, V, = -18.7 mV, 
k = 6.7 mV, andI,s = 12 pA, 
respectively. (B) Effect of 
(-)BAY K 8644 on the voltage 
dependence of 1B~ availability. 
Under control conditions (O) 
/max = 80 pA, Vh = -17.8 mV, 
k = 5.7 mV, andl~ = 16 pA, 
and after application of 1 ~M 
(-) BAY K 8644 ( I )  Imax = 190 
pA, Vh = -19.3 mV, k = 8.36 
mV, and I~, = 15 pA, respec- 
tively. 
ing shifts induced by 10 nM, 100 nM, and 1 I~M of ( - )202 791 were 5.3, 10.3, and 
17.7 mV (n = 3), respectively. The antagonist enantiomers hifted the inactivation 
curve by a substantial amount in the hyperpolarizing direction even on application of 
low drug concentrations that had little effect on the peak current value (Figs. 3 and 
6). The slowly inactivating component of the inward current was more affected by the 
antagonist enantiomers (Fig. 3) than by the agonist enantiomers (Fig. 1). 
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Action of the Enantiomers of Sandoz 202 791 and BAY K 8644 under 
Nonequilibrium Conditions 
On and off rates for drug action can be approximated by monitoring of  calcium 
channel currents and fast application of  drug during the pulse train. In a biomolec- 
ular binding reaction, the rate for drug binding changes with concentration in a 
manner predicted by the law of mass action. The plot of  l/'r against drug concentra- 
tion will give a straight line with a slope Kx and the intercept of  the line with ordinate 
axis is K-I.  We investigated the onset rate of  action of  the agonist and antagonist 
A 
ANTAGONIST8 
1.0 
( -)202 7'91 
w 0 0.5 (-)202 7'91 
Z 
0 
-7'5 -50 -25 0 25 
%,o(mV) 
w., 1.o ~~ 
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o.s 
o 
-75 -50 -25 0 25 
Vpre(nlV) 
FIGURE 6. (A) Effect of the 
antagonist (-)202 791 on the 
voltage dependence o f lh  avail- 
ability. For the control (0) 
lm~ = 72 pA, Vh = -- 12.9 mV, 
k = 9.7 mV, I ,  = 6 pA, after 
application (A) of 0.1 IzM 
(-)202 791 Im~ = 42 pA, Vh = 
--29.4 mV, k = 6.6 mV, and 
I ,  = 0 pA, and ( . )  after appli- 
cation of 1 I~M (-)202 791 
/max = 31 pA, Vh = -33.6 mV, 
k = 5.8, and I ,  = 0, respec- 
tively. (B) Effect of (+)BAY K 
8644 on the voltage depen- 
dence of IBa availability. Under 
control conditions (Q) Ima~ = 
69pA, Vh = -20.0 mV, k = 5.5 
mV and Iss = 5pA and after 
application of 1 o.M (+)BAY K 
8644 (m) /max = 34 pA, Vh = 
--42.8 mV, k = 6.0 mV and 
I ,  = 0 pA, respectively. 
compounds at different membrane potentials. For this purpose the cell was depolar- 
ized from different holding potentials at a frequency of 1 Hz to a potential of  +30 
mV by short (20 ms) test pulses and the drug was applied in a concentration jump 
between two successive test pulses of the pulse train (Fig. 7). The experiments were 
designed to minimize the amount of inactivation during a test pulse and to observe at 
the same time the rate of  onset of  drug action at a negative holding potential. To 
exclude possible artifacts of  a superimposed rundown of  the currents, the peak 
current amplitude of the inward current was monitored uring a 1-Hz train of 20-ms 
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pulses before each drug application. Only cells with stable current amplitudes over 
periods of  2 min were used in these studies. Fig. 7 A shows the increase in current 
amplitude after a concentration jump with 1 I~M (+)202 791 during an experiment 
where the test pulses were applied from a holding potential of  -60  mV to a test 
potential of  +30 mV. The increase in peak current amplitude on application of  a 100 
times lower concentration of (+)202 791 ( I0 nM) is shown in Fig. 7 B. ( -)BAY K 
A I wM (+) :O!  7el 
TIME (m): 1 8 6 7 8 9 10 11 12 13 
S 10 nM (+)202 191 
100 pA 
'too ms 
TIME (s): 1 5 6 8 10 12 14 16 18 20 
300 
250 
200 
t50 
tO0 
-~ 50 
0 
0 
T-  1.7e 
T -5 .2s  
TIME AFTER DRUG APPLICATION (s) 
FIGURE 7. Rate of onset of action of 
agonist enantiomers when applied 
rapidly at negative membrane poten- 
tials during a train of brief pulses. (A) 
Increase in IBa at -60 mV holding 
potential during a 1-Hz pulse train of 
20-ms test pulses to +30 mV after a 
concentration jump with 1 p,M 
(+)202 791. Drug application be- 
tween pulses five and six led to a 
rapid increase in the peak current 
amplitude, which reached a steady- 
state value after 12 s. Note the acceleration i  the rate of current decay but no detectable 
change in the tail current kinetics after application of the agonist. (B) Increase in I~ on 
application of 10 nM (+)202 791. Same protocol as in A. (C) Exponential fits to the 
time-dependent i crease in peak Isa on application of 1 p.M(+)202 701 (ll), 1 o.M (-)BAY K 
8644 (O), and 10 nM (+)202 791 (&). The estimated time constants are indicated in Fig. 8 B. 
8644 (1 IxM) was also tested at -60  mV; its onset time constant was 2.3 - 0.2 s 
(n = 4). The time course of  the increase in peak IBa on application of  agonist 
enantiomers during a pulse train could be fitted by a single exponential function (see 
Fig. 7 C). The mean time constants of  the exponential increase in IBa when 1Ba was 
evoked from different holding potentials are given in Fig. 8 B. As shown, the 
1/Xincr~ase plot at --60 and -80  mV can hardly be approximated by a linear regression 
line. For ( - )202 791 (Fig. 8 A) those plots are indistinguishable for large hyperpolar- 
HERING ET AL Calcium Channel Modulation by t,4-Dihydropyridines 403 
izations ( -80  and -60  mV). Faster onset of  drug action was observed at -40  mV 
holding potential.  The est imated values for Ko compared with the values obtained 
from steady-state concentrat ion-response relationships at various holding potentials 
are shown in Table II. There were no significant differences in the unbinding rates 
for the agonist drug within a voltage range from -80  to -40  mV. As shown in Table 
II, the off rates (K-I) deduced from the drug onset kinetics (Fig. 8) are in good 
agreement  with the drug off rates (Ko~) est imated by rapid washout of  drug in 
concentration jump experiments.  To determine whether the action of the antagonist 
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FIGURE 8. Rate of development (on- 
set) of antagonist ((-)202 791) and 
agonist ((+)202 791) action at -40, 
-60, and -80  mV as a function of 
applied drug concentration. Drug was 
applied in concentration jumps dur- 
ing a train of brief test pulses. (A) 
l/~blo~k of peak IBa inhibition at -40  
(I-q), -60  (A), and -80  mV (O) hold- 
ing potential during a l-Hz pulse 
train of 20-ms test pulses to +30 mV 
after application of 0.1, 1, and 3 I~M 
(-)202 791. Estimated rug on rates 
are Kt[D] = 0.6 x 105 M -l s -~ at -40  
mV, KI[D] = 0.3 x 105 M -1 s -1 at 
-60  mV, and KI[D] = 0.3 x 105 M -1 
s -l at -80  mV. (B) 1/'rm .. . . .  of peak 
IB~ at --40 (ll), --60 (A), and -80  mV 
(0) holding potential during a 1-Hz 
pulse train of 20-ms test pulses to 
+30 mV; application of 0.01, 0.1, and 
1 I~M (+)202 791. Points are con- 
nected by lines; linear regression 
analysis at -40  mV ( I )  reveals 
KI[D] = 5 x 10 5 M -1 s -|. Data points 
in A and B represent mean values -+ 
SD of three to seven experiments. 
The values for KI, which were estimated from the y-intercept of the linear regression lines, are 
shown in Table II. In most of the studied cells we could observe 80-90% recovery from drug 
action on rapid application of drug-free high-barium solution. 
was dependent  on the opening of  the calcium channels, we tested the rate at which 
peak current was reduced on appl icat ion of  2 tzM ( - )202  791 during 20-ms pulses to 
+30 mV appl ied from a holding potential  of  -50  mV at different pulse frequencies. 
In Fig. 9 A drug was appl ied during a 1-Hz pulse train and in Fig. 9 B the drug was 
appl ied 2 s after the last control current dur ing a 0.2-Hz pulse train. Fig. 9 C displays 
the time course of  the peak current inhibit ion after the drug appl icat ion in this 
exper iment.  The rates of onset of antagonism at the two pulse frequencies were very 
similar. 
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Currents evoked from a holding potential  of  -60  mV to a test potential  of  +20 mV 
displayed a biphasic inactivation time course with a fast inactivation time constant of  
156 +-- 49 ms and a slow inactivation t ime constant of  5,250 -+ 2,709 ms (n = 4). The 
agonist enant iomer (+)202 791 (1 IxM) was appl ied dur ing the slowly inactivating 
component  of  the inward current dur ing a 6-s voltage jump to +20 mV (Fig. 10A). 
A 2 pM 02O2 781 
TIME (t): 1 5 e 7 8 9 10 16 20 25 
8 2 ~ ( - )202 7e 1 
100 ms 
TIME (s): 1 5 10 15 20 25 30 
C 
100 
i o, , i "i = ; 
0 5 I0 15 20 
TIME AFTER DRUG APPLICATION (s) 
FIGURE 9. Rate of onset of action of 
(-)202 791 at a holding potential of 
-50  mV. (A) 2 ~M (-)202 791 was 
applied between pulses five and six of 
a 1-Hz train of 20-ms pulses to +30 
mV. Currents before and at selected 
time intervals after drug application 
are shown to illustrate the gradual 
inhibition of the peak IBa. (B) 2 p.M 
(-)202 791 was applied by a concen- 
tration jump 2 s after the second 
pulse in a 0.2-Hz pulse train of 20-ms 
test pulses to +30 mV. Inward cur- 
rents at selected time intervals are displayed. (C) Time course of the inhibition of the inward 
current during a pulse train at -50  mV in two cells of A and B stimulated at different rates (0.2 
and 1 Hz). The rate of block is very similar, suggesting that brief activations of the inward 
current do not significantly affect the rate of block. 
The increase in inward current produced by 1 p~M (+)202 791 is shown with a 
monoexponent ia l  fit in Fig. 10 B. A mean time constant of  380 - 80 ms (n = 3) was 
estimated for the net increase in inward current on appl icat ion of  1 p,M (+)202 791 
2-3 s after the voltage step to 20 mV dur ing the slowly inactivating component  oflBa 
(Fig. 10; see also Fig. 8 in Her ing et al., 1989b). However, shortly after appl icat ion of 
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I pM (+)  202  791 
mv 
1 ~M(+) 202 701 
I kT -  0.22 s I 
l I 
(s) 
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FIGURE 10. Application of (+)202 
791 at a depolarized membrane po- 
tential The-barium current was acti- 
vated by a 6-s voltage steps from -60 
to +20 mV. (A) 1 wM (+)202 791 was 
applied by a concentration jump 2 s 
after the voltage jump (I). 2 shows the 
barium current at the second pulse in 
the presence of the drug after a rest 
period of 10 s at the holding potential 
of -60 mV. (B) The net increase in 
lh  is shown. This was obtained by 
digital subtraction of the control cur- 
rent decay during the previous pulse 
in the absence of (+)202 791 from the 
current after application of 1 o.M 
(+)202 791. The activation of the 
agonist-induced current was fitted to 
a monoexponential function and 
yielded a time constant of 220 ms. 
the drug, its effect on channel kinetics rapidly reached equilibrium, and thus the 
amount of current at the end of the 6-s-depolarizing step when the drug was applied 
was 12 pA; it was 13 pA at the end of the next depolarizing pulse applied after a 10-s 
rest at -60  mV in the presence of the drug (cf. Fig. 10A, 1 and 2). The decay of 
current during the last 3 s of the pulse was virtually the same. This latter observation 
implies that the rate of channel transitions out of or into the open state may be 
unchanged. 
DISCUSSION 
In this study we observed a pronounced similarity between the actions of the DHPs 
Sandoz 202 791 and BAY K 8644 on the calcium channel current in rabbit ear artery 
cells. The agonist enantiomers of both drugs induced a larger increase in peak 
current during small than during large depolarizations, and also caused a shift in the 
peak of the current-voltage r lationship and activation curve to more hyperpolarized 
voltages (see Figs. 1 and 2 and Table I). In contrast, the antagonist enantiomers of 
both drugs were more potent during depolarizations to membrane potentials where 
the channels have a high open probability and undergo inactivation. A smaller 
inhibitory effect on the peak current values of IBa was observed in the voltage range 
of -30  to -10  mV (see Figs. 3 and 4 and Table II). The agonist enantiomers, in 
contrast, had less effect on the sustained component of the barium inward current. In 
this respect our results confirm the findings of earlier electrophysiological studies 
where similar changes in the current-voltage r lationship of the calcium channel 
current caused by DHPs have been reported for various tissues (Hess et al., 1984; 
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Sanguinetti, Krafte, and Kass, 1986; Caffrey, Josephson, and Brown, 1986; Bean, 
Sturek, Puga, and Hermsmeyer, 1986; Markwardt and Nilius, 1988). The observed 
dissimilar effects of agonist and antagonist DHPs under steady-state conditions (Figs 
1, 3, 5 and 6) may indicate selective binding of agonists to closed available or open 
channel conformations, while antagonists bind with a higher affinity to inactivated 
(Bean, 1984; Sanguinetti and Kass, 1984) and/or open conformational states of 
calcium channels or promote inactivation by accelerating the state transition rates to 
inactivated channel states (Hexing et al., 1989b). 
Voltage-dependent O set Rates for Agonist Action: Implications for State-dependent 
Agonist DHP Binding 
Similar agonist concentrations applied at different membrane potentials induce 
different rates of current increase. The rate of increase of inward current on rapid 
application of 1 ~M (+)202 791 during a single test pulse at +20 mV in the 
concentration jump experiment in Fig. 10A is nearly monoexponential and faster 
than the current increase induced by a similar agonist concentration applied at more 
negative membrane potentials during repetitive application of short depolarizing 
pulses (Fig. 7). A slower onset of agonist action during weak compared with strong 
depolarizations has been previously shown in heart cells (Hering et al., 1989b). 
Lacerda and Brown (1989) speculated that a rate-limiting step is partitioning of 
DHPs into the membrane. The observed ifference in the time constants for agonist 
action at different membrane potentials uggests, however, that the accessibility of 
the receptor is not rate limiting. This finding is supported by recent findings of Kass, 
Arena, and Chin (1991), with evidence for an extracellular localization of the DHP 
receptor. Different onset rates of agonist action at different membrane potentials 
may reflect state-dependent drug binding, i.e., a higher affinity of agonist DHPs to 
open states. Alternatively, the observed ifferences in onset kinetics of drug action 
may reflect voltage dependence of drug association and/or dissociation, or a 
redistribution of unbound and drug-bound channels between different channel 
states. Hence, under nonsaturating drug concentrations there will be a mixture of 
both nonmodified and drug-modified channels. The former may have normal rate 
constants and the latter rate constants modulated by drug. Thus, deviations of the 
association rate constants from a simple bimolecular kinetics (Fig. 8 B) may reflect 
the fact that movement of channels into the DHP-bound state depends on both 
concentration-dependent and concentration-independent rate constants. At high 
drug concentrations channel state transition rates might become rate limiting. Thus, 
in concentration jump experdments he onset picture could be camouflaged by the 
redistribution of channels between states of drug-bound channels with modified 
gating. In other words, monitoring of drug onset by peak current measurement 
during a train and subsequent interpretation of the data assuming simple bimolecu- 
lar kinetics may not always be adequate. 
Voltage-dependent O set Rates for Antagonist Action: Implications for 
State-dependent A tagonist DHP Binding 
These studies demonstrate hat the affinity for the antagonist (-)202 791 is increased 
at a depolarized membrane potential ( -40 mV; see Table II and Fig. 8). These 
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findings are consistent with the hypothesis proposing that DHP antagonists possess 
high affinity for inactivated states of the calcium channel (Bean, 1984). Under 
conditions of microscopic reversibility, an increased affinity of drug for the inacti- 
vated state implies that the drug alters the transition rate of channels into or out of 
inactivated states, since under these conditions binding rate constants and channel 
transition rates are interdependent. However, the evidence that antagonists bind 
selectively to inactivated (as opposed to open) states is not unequivocal. Hence, the 
inhibition of the sustained current component and faster apparent inactivation (see 
Lee and Tsien, 1983; Gurney, Nerbonne, and Lester, 1985), but also increased 
potency at depolarized voltages can be explained by open channel block. On the 
other hand, an additional component of block for drugs with high affinity to 
inactivated channel states would be expected in such a case during high frequency 
depolarization. In this study the observed rates of antagonist-induced current decay 
at -50  mV were very similar during pulse trains of 0.2 and 1 Hz. Similar observations 
were made for other antagonist DHPs in smooth muscle (Terada et al. 1987; Hering 
et al., 1988) under different experimental conditions. This obvious discrepancy of 
1,4-DHP action in smooth muscle with the suggested similarity in 1,4-DHP action to 
the effect of local anesthetic on sodium channels could be explained by a very rapid 
unbinding of drug at negative holding potentials between the individual test pulses of 
a train. Various experimental findings do not, however, agree with such an assump- 
tion: (a) Hess, Lansman, and Tsien (1985) have shown that nitrendipine and 
nimodipine do not affect he mean open time of calcium channels in ventricular cells 
but increase the percentage ofnull sweeps. Thus, if the drugs bind selectively to used 
channels (in the O or I state) the channels remain blocked for several sweeps. (b) 
Kinetic studies of drug action in whole-cell experiments also reveal slow unbinding 
rates of drug (rate constant of ~ 0.02 s-l; see Fig. 8 and Table II; see also results of 
Bean [1984] with K-1 = 0.0012 s-l). The correlation between the values for 
unbinding of drug estimated in concentration jump experiments (Kofr) and the values 
calculated with the y-intercept method (K-l; Fig. 8) indicates that the time constants 
observed in concentration jump experiments reflect binding and unbinding of drug 
to the DHP receptor. 
The interpretation of antagonist DHPs induced changes in whole-cell current 
kinetics (i.e., accelerated apparent inactivation time course; Fig. 3) is also compli- 
cated by the possibility that the transient component of current decay is at least 
partially determined by inactivation of T-type channels (Benham et al., 1987). The 
pronounced increase in the transient component of current in smooth muscle in the 
presence of agonist DHPs (Fig. 10; see also Bean et al., 1986) suggests, however, that 
the rapidly decaying current is not entirely T-type current but represents a fast 
kinetic component of L-type channels. It has been shown by Hering et al. (1988) that 
nifedipine acts very slowly in smooth muscle cells when applied during a single 
voltage clamp step to depolarized voltages. In contrast in cardiac cells, (-)202 791 
(I ~,M) acts fairly rapidly with an onset time constant of ~ = 200 ms (Hering et al., 
1989b). It is unclear whether this difference is a pecularity of nifedipine or a general 
difference between calcium channels in smooth muscle and heart cells. Further 
studies will be necessary to resolve this question. Nevertheless, it is worth noting that 
the association kinetics of different DHPs vary considerably in radioligand binding 
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studies with purified calcium channels even between two antagonist enantiomers of 
the same compound (Knaus, Striessnig, Hering, Marrer, Schwenner, H61tje, and 
Glossmann, 1992). 
In conclusion, we believe that the kinetic analysis of agonist and antagonist DHP 
action in concentration jump experiments has great potential for revealing new 
aspects of their state-dependent action and drug-induced changes in channel gating. 
This approach may be helpful in answering a number of unresolved questions 
regarding the interaction of DHPs with voltage-dependent calcium channels, such as 
whether different compounds can be distinguished by specific on and off rates in 
electrophysiological experiments; whether DHPs act by binding to a single receptor 
site or multiple receptor sites (Kamp, Sanguinetti, and Miller, 1989; Hughes, Hering, 
and Bolton, 1990; Mironneau, Yamamoto, Sayet, Arnaudeau, Rakotoarisoa, and 
Mironneau, 1992); and whether differences exist between DHP action on voltage- 
dependent calcium channel in cardiac and smooth muscle. 
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